Skip to main content
Internal Medicine Geriatrics and Gerontology

Geriatrics and Gerontology

Open Access Diabetes Review

Understanding bone metabolism in diabetes

Skeletal fragility in diabetes is associated with a significant clinical burden. Using diabetes-specific parameters may help address gaps in the assessment and management of diabetic bone disease.

Increased fall risk with antihypertensives

24-05-2024 Hypertension News

Older nursing home residents starting antihypertensive medication may be at increased risk for fall-related fractures within 30 days of initiation.

Sarcopenic obesity and cardiovascular disease

Open Access Obesity Review

Sarcopenic obesity is an emerging risk factor for CVD, particularly in older adults. Optimizing its treatment and management will become increasingly important as the global population ages.

Potential neuroprotection in cardiac arrest-induced coma

21-05-2024 Coma News

Acyl-ghrelin given within 12 hours of resuscitation may improve neurological outcome of patients in a coma after cardiac arrest.

Temporal artery ultrasound efficient for diagnosis of giant cell arteritis

20-05-2024 Giant Cell Arteritis News

An ultrasound-first strategy can diagnose giant cell arteritis rapidly and effectively, and avoid the need for temporal artery biopsy in around two-fifths of cases.

Webinar | 02-05-2024 | 17:30 (CEST)

Keynote webinar | Spotlight on sleep in brain health

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Dr. Rolf Fronczek
Dr. Renata Riha
Dr. Sven Rupprecht
Developed by: Springer Medicine

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Current Reviews

An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer

Milwaukee, the most populous city in Wisconsin, has high rates of health inequities among segregated communities and neighborhoods with living conditions below the poverty level [ 1 – 3 ]. Many communities with individuals from historically and …

Definitions and adverse outcomes of sarcopenia in older patients in orthopedic and trauma care: A scoping review on current evidence

Open Access Sarcopenia Review Article

Sarcopenia is characterized by a decline of muscle mass and strength and is prevalent in 10–27% of individuals over 60 years old [ 1 ]. Despite the heightened interest in sarcopenia research, as illustrated by the annual increase of 18% in the …

Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis

Breast cancer is the leading cause of cancer-related mortality in women worldwide [ 1 , 2 ]. A diagnosis of breast cancer (stages I–III) leads a person into an unfolding sequence of treatments that include a combination of neoadjuvant chemotherapy …

Sarcopenia predicts postoperative complications in head and neck cancer: a systematic review and meta-analysis

Sarcopenia Review Article

Head and neck cancer (HNC) is one of the most common malignancies worldwide [ 1 ]. For patients with early stage or locoregionally advanced HNC, surgery is a curative treatment choice with or without postoperative (chemo)radiotherapy [ 2 ].

Alzheimer's Disease Independent Medical Education

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by: Lilly

Developed by: Springer Healthcare IME

Case Studies

Hypotensive twilight zone in Parkinson’s disease

Free for a limited time Parkinson's Disease Case Study

Almost daily episodes of reduced responsiveness lasting up to an hour, with the patient slumped back in a chair but staying upright, indicated an under-recognised presentation of orthostatic hypotension.

Suspected ADHD in an older adult with bipolar disorder

Open Access Mental Health in Older People Case Study

Comorbid ADHD and bipolar disorder in older adults may go unrecognized and untreated, but this case shows that improved quality of life and functioning can be achieved safely with psychostimulant medications.

Unique presentation of memantine overdose

Open Access Medical Side Effect Case Study

Hypertensive urgency and echolalia were the most striking symptoms of memantine overdose in an elderly man with mild dementia and hypertension. Early medication review with caregivers of people with dementia is key.

News | Vodcasts | Podcasts (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Emerging biomarkers and disease-modifying therapies for Alzheimer’s disease promise significant changes in how the condition is diagnosed and managed.

Guide yourself through this transition with our education program, led by world renowned experts and covering the biggest international conferences.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Webcast | eLearning | Infographic (Link opens in a new window)

PET biomarkers are fast becoming critical in the new era of disease modification for Alzheimer’s disease. Techniques around amyloid and tau require the expertise of nuclear medicine and radiology physicians to investigate and interpret PET scans in clinical settings. This program examines current and emerging biomarkers and assists in identifying patterns from different PET tracers in an interactive perceptual learning environment.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Further Reading

CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism

Open Access Checkpoint Inhibitors Original Article

Gastric cancer (GC) is the fifth common cancer and the third leading cause of cancer-related death worldwide [ 1 ]. Since the ATTRACTION-2 study [ 2 ] and the KEYNOTE-059 study [ 3 ], immune checkpoint inhibitors (ICIs) have been recommended for …

Definitions and adverse outcomes of sarcopenia in older patients in orthopedic and trauma care: A scoping review on current evidence

Open Access Sarcopenia Review Article

Sarcopenia is characterized by a decline of muscle mass and strength and is prevalent in 10–27% of individuals over 60 years old [ 1 ]. Despite the heightened interest in sarcopenia research, as illustrated by the annual increase of 18% in the …

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

Open Access Sarcopenia Original Research

Sarcopenia may increase non-alcoholic fatty liver disease (NAFLD) risk, but prevalence likely varies with different diagnostic criteria. This study examined the prevalence of sarcopenia and its defining components in adults with and without NAFLD …

Evaluation of a new two-step frailty assessment of head and neck patients in a prospective cohort

Open Access Geriatric Assessment Head and Neck

The median age of the global population is rising, and consequently the median age of all cancer patients as well as of patients with head and neck cancer (HNC) [ 1 , 2 ]. Since HNC is the sixth most common malignancy worldwide and its incidence is …

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Webinar | 08-11-2023 | 18:00 (CET)

Keynote webinar | Spotlight on diet and diabetes

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean
Prof. Falko Sniehotta
Developed by: Springer Medicine